Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Cerevel Therapeutics Holdings Inc | 15.04% | 8.62bn |
ImmunoGen Inc | 20.09% | 10.22bn |
Data delayed at least 15 minutes, as of Apr 25 2024 15:56 BST.
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 31 Dec 2023 | 415.82k | 0.00% |
Bram Bradesco Asset Management S/A DTVMas of 31 Dec 2023 | 64.30k | 0.00% |
XP Allocation Asset Management Ltda.as of 31 Dec 2023 | 1.12k | 0.00% |
Data from 31 Dec 2023 - 17 Apr 2024Source: FactSet Research Systems Inc.